Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up―A Copenhagen Experience

Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours

(2020) Kristian Almstrup et al.   Nature Reviews Urology

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic

(2019) João Lobo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

(2019) Klaus-Peter Dieckmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment

(2019) Klaus-Peter Dieckmann et al.   Biomed Research International

International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries

(2019) Jason K. Gurney et al.   EUROPEAN UROLOGY

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy

(2019) Ximena Rosas Plaza et al.   Cells

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data

(2019) João Lobo et al.   Cells

Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor

(2018) Ricardo Leão et al.   JOURNAL OF UROLOGY

Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation

(2018) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1

(2018) Arlo Radtke et al.   UROLOGIA INTERNATIONALIS

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients

(2018) Angelika Terbuch et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

(2017) Klaus-Peter Dieckmann et al.   EUROPEAN UROLOGY

Stability of Circulating Blood-Based MicroRNAs – Pre-Analytic Methodological Considerations

(2017) Charlotte Glinge et al.   PLoS One

The present and future of serum diagnostic tests for testicular germ cell tumours

(2016) Matthew J. Murray et al.   Nature Reviews Urology

MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid

(2016) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)

(2016) Ton van Agthoven et al.   Oncotarget

A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program

(2014) Mette Saksø Mortensen et al.   EUROPEAN UROLOGY

Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort

(2014) Gedske Daugaard et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker

(2014) M. Spiekermann et al.   Andrology

Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle

(2013) Ad J.M. Gillis et al.   Molecular Oncology

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

(2012) K-P Dieckmann et al.   BRITISH JOURNAL OF CANCER

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

(2010) Timothy D. Gilligan et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum tumor markers in testicular cancer

(2010) Yaron Ehrlich et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS